BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28329269)

  • 1. Proteomics highlights decrease of matricellular proteins in left ventricular assist device therapy†.
    Shahinian JH; Mayer B; Tholen S; Brehm K; Biniossek ML; Füllgraf H; Kiefer S; Heizmann U; Heilmann C; Rüter F; Grapow M; Reuthebuch OT; Eckstein F; Beyersdorf F; Schilling O; Siepe M
    Eur J Cardiothorac Surg; 2017 Jun; 51(6):1063-1071. PubMed ID: 28329269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of left ventricular assist device therapy on the cardiac proteome and metabolome composition in ischemic cardiomyopathy.
    Shahinian JH; Rog-Zielinska EA; Schlimpert M; Mayer B; Tholen S; Kammerer B; Biniossek ML; Beyersdorf F; Schilling O; Siepe M
    Artif Organs; 2020 Mar; 44(3):257-267. PubMed ID: 31494943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of mechanical unloading on structural and nonstructural components of the extracellular matrix in advanced human heart failure.
    Sakamuri SS; Takawale A; Basu R; Fedak PW; Freed D; Sergi C; Oudit GY; Kassiri Z
    Transl Res; 2016 Jun; 172():30-44. PubMed ID: 26963743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic profiling of the human failing heart after left ventricular assist device support.
    de Weger RA; Schipper ME; Siera-de Koning E; van der Weide P; van Oosterhout MF; Quadir R; Steenbergen-Nakken H; Lahpor JR; de Jonge N; Bovenschen N
    J Heart Lung Transplant; 2011 May; 30(5):497-506. PubMed ID: 21211997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcomeric genes involved in reverse remodeling of the heart during left ventricular assist device support.
    Rodrigue-Way A; Burkhoff D; Geesaman BJ; Golden S; Xu J; Pollman MJ; Donoghue M; Jeyaseelan R; Houser S; Breitbart RE; Marks A; Acton S
    J Heart Lung Transplant; 2005 Jan; 24(1):73-80. PubMed ID: 15653383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ventricular unloading induces cardiomyocyte proliferation.
    Canseco DC; Kimura W; Garg S; Mukherjee S; Bhattacharya S; Abdisalaam S; Das S; Asaithamby A; Mammen PP; Sadek HA
    J Am Coll Cardiol; 2015 Mar; 65(9):892-900. PubMed ID: 25618530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern.
    Bruggink AH; van Oosterhout MF; de Jonge N; Ivangh B; van Kuik J; Voorbij RH; Cleutjens JP; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Sep; 25(9):1091-8. PubMed ID: 16962471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term mechanical unloading and reverse remodeling of failing hearts in children.
    Mohapatra B; Vick GW; Fraser CD; Clunie SK; Towbin JA; Sinagra G; Vatta M
    J Heart Lung Transplant; 2010 Jan; 29(1):98-104. PubMed ID: 19783184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support.
    Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left-Ventricular Assist Device Impact on Aortic Valve Mechanics, Proteomics and Ultrastructure.
    Stephens EH; Han J; Trawick EA; Di Martino ES; Akkiraju H; Brown LM; Connell JP; Grande-Allen KJ; Vunjak-Novakovic G; Takayama H
    Ann Thorac Surg; 2018 Feb; 105(2):572-580. PubMed ID: 29223417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular changes after left ventricular assist device support for heart failure.
    Birks EJ
    Circ Res; 2013 Aug; 113(6):777-91. PubMed ID: 23989719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support.
    Lok SI; Winkens B; Goldschmeding R; van Geffen AJ; Nous FM; van Kuik J; van der Weide P; Klöpping C; Kirkels JH; Lahpor JR; Doevendans PA; de Jonge N; de Weger RA
    Eur J Heart Fail; 2012 Nov; 14(11):1249-56. PubMed ID: 22843564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
    Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
    J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transcriptional regulation of α-1-antichymotrypsin by microRNA-137 in chronic heart failure and mechanical support.
    Lok SI; van Mil A; Bovenschen N; van der Weide P; van Kuik J; van Wichen D; Peeters T; Siera E; Winkens B; Sluijter JP; Doevendans PA; da Costa Martins PA; de Jonge N; de Weger RA
    Circ Heart Fail; 2013 Jul; 6(4):853-61. PubMed ID: 23640964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
    Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
    J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
    Demirozu ZT; Arat N; Kucukaksu DS
    Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Center Experience With HeartMate II Left Ventricular Assist Device Explantation.
    Tchantchaleishvili V; Cheyne C; Sherazi S; Melvin AL; Hallinan W; Chen L; Todd Massey H
    Artif Organs; 2016 Dec; 40(12):1145-1149. PubMed ID: 27076358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
    Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
    J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.